Skip to main content
lexblog.com/lib/5B59KYZBviewrecordjson
LEX-WK-5B59KYZBcrawled 2025-10-22 06:41Z

Key IP Licensing Considerations for AI Drug Discovery Platforms

Dan Shores · Michael Ellenberger · RF EMerge · Published October 17, 2025

Work details

firm or organization
Rothwell Figg
publication
RF EMerge
published
2025-10-17

Citation

Dan Shores, Michael Ellenberger, Key IP Licensing Considerations for AI Drug Discovery Platforms, RF EMerge (October 17, 2025) [The Library at LexBlog, LEX-WK-5B59KYZB, lexpid.org/5B59KYZB]